Remove law us-supreme-court
article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

Amgen could be the winner of a high-stakes patent spat with Sanofi as tensions run high weeks before the March 27 US Supreme Court hearing. While some courts were previously on Sanofi’s side, it is possible that Amgen’s case could win this time, some legal experts say. However, the case was brought back.

104
104
article thumbnail

Supreme Court backs Sanofi in high-profile cholesterol drug suit with Amgen

Pharmaceutical Technology

The US Supreme Court has unanimously voted in favour of Sanofi and Regeneron in a years-long legal feud with Amgen over the potential patent infringement surrounding the companies’ anti-cholesterol drugs. After previously receiving the arguments from both companies on March 27, the Supreme Court delivered its verdict on May 18.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Alabama could face prosecution over use of abortion pills

pharmaphorum

The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made access to the drugs easier. ” The post Women in Alabama could face prosecution over use of abortion pills appeared first on.

article thumbnail

Pharma in Brief’s 2023 Year in Review and Trends for 2024

Pharma in Brief

As you start the new year, allow us to recap 2023’s important legal and regulatory developments for Canadian pharma. Other notable developments in 2023 included increased fees for patent and trademark applications, patent law decisions from the courts, and Federal Court guidance on artificial intelligence.

article thumbnail

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

STAT

As always, you are invited to join us. Supreme Court overturned Roe v. Wade , The Hill tells us, citing a study in JAMA. The evidence presented itself early this morning as the official mascots dashed about the grounds to bark about passersby, and a steady parade of driving machines could be seen from our window.

article thumbnail

Big three distributors claim win in $2.5bn WV opioid case

pharmaphorum

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of lives in the state. District court judge David Faber rejected a call by prosecutors to force the distributors to pay $2.5

article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law Blog: Biosimilars

Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts. A recent state law failure-to-warn case in the SDNY makes that very point.